Editor Conflict of Interest Disclosures

A PDF of the Editors' conflict of interest disclosure information is available for download here.

Leadership: Tesaro

Consulting or Advisory Role: ZIOPHARM Oncology, Conatus

Honoraria: Pfizer

Consulting or Advisory Role: UnitedHealthcare

Research Funding: Novartis

Honoraria: Pfizer, Genentech/Roche

Speakers' Bureau: Pfizer

No conflicts to report

Honoraria: Prime Oncology, Elsevier, Itamar Medical

Consulting or Advisory Role: Monteris Medical, Incyte, AstraZeneca, Bristol-Myers Squibb, Abbvie

Research Funding: Novartis, TRACON Pharma, Novocure, Spectrum Pharmaceuticals, Lilly/ImClone, Boehringer Ingelheim

No conflicts to report

Stock & Other Ownership Interests: Aerocrine

Honoraria: Lilly

Consulting or Advisory Role: Aerocrine, Celgene, Thermo Fisher Scientific, Biodesix

Travel, Accomodations, Expenses: Lilly, Celgene

Consulting or Advisory Role: INC Research and Cyt RX, Marathon Pharma, Morphotek

No conflicts to report

No conflicts to report

Leadership: Artelo

Stock & Other Ownership InterestsPRM Pharmaceutical, Artelo Pharma, Madorra

Consulting or Advisory Role: Clinical Oncology Advisory Group, Bristol-Myers Squibb, Apotex, Physician Resource Management, OnQ, Cascadian Therapeutics, Varian Medical Systems, Mylan, Tersera, BeyondSpring Pharmaceuticals

Research Funding: Amgen, BeyondSpring Pharmaceuticals

Honoraria: AstraZeneca, Bristol-Myers Squibb, Biodesix, Merck, Pfizer, Roche/Genentech, Trovagene, Lilly

Consulting or Advisory Role: AstraZeneca, Bristol-Myers Squibb, Biodesix, Merck, Pfizer, Roche/Genentech, Trovagene, Lilly

Research Funding: AstraZeneca, Bristol-Myers Squibb, Corvus Pharmaceuticals, Five Prime Therapeutics, Biodesix, Roche/Genentech, Lilly, Merck, Pfizer

Employment: WellVia

Leadership: WellVia

Stock & Other Ownership Interests: SirenMD, AVIA, EpicMD

Honoraria: WellVia, EpicMD, SirenMD

Travel, Accommodations, Expenses: WellVia, SirenMD, EpicMD

No conflicts to report

Employment: Flatiron Health

Patents, Royalties, & Other Intellectual Property: Patents pending relating to inventions as employee of NCCN

Other Relationships: National Comprehensive Cancer Network

No conflicts to report

No conflicts to report

Employment: Texas Oncology, University of Texas Southwestern Medical Center - Simmons Cancer

Leadership: Texas Oncology, Parkland Health System

Stock & Other Ownership Interests: Amgen, Medfusion, Merck, Pfizer

Research Funding: US Oncology

Other Relationships: Mary Crowley Research Center (Dallas, Texas), American Society of Clinical Oncology, Methodist Health System (Dallas, Texas)

Consulting or Advisory Role: Bayer, MDx, Genomic Health, Janssen Pharmaceuticals, Dendreon and Ferring

Research Funding: National Institutes of Health, University of Colorado Cancer Center

Employment (spouse): Dendreon

No conflicts to report

Leadership: Blueprint Medicines

Stock & Other Ownership Interests: Blueprint Medicines, G1 Therapeutics, Bessor Pharma, Caris Life Sciences, Champions Oncology, N-of-One

Consulting or Advisory Role: Bayer, Pfizer, Novartis, Lilly, EMD Serono, Sanofi, Janssen Oncology, PharmaMar, Daiichi Sankyo, Blueprint Medicines, Kolltan Pharmaceuticals, WIRB-Copernicus Group, ZIOPHARM Oncology, Polaris, Nektar, Genocea Biosciences, G1 Therapeutics, Caris Life Sciences, Adaptimmune, Eisai, Kyocera

Research Funding: Abbvie, Janssen Oncology

Patents, Royalties, & Other Intellectual Property: Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber and Novartis

No conflicts to report

No conflicts to report

Consulting or Advisory Role: AMAG Pharmaceuticals, ARIAD, Biodesix, Boehringer Ingelheim, Eisai, Gilead Sciences, Helsinn Therapeutics, Lilly, Roche/Genentech

Research Funding: Puma Biotechnology

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Merck, Astellas Pharma

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Merck, Lilly

Other Relationships: Breast Cancer Research Foundation

Honoraria: CMP Healthcare Oncology Publishing, The ASCO Post

Consulting or Advisory Role: CommGeniX, International Genetics, AlphaSights

Travel, Accommodations, Expenses: Hospital Association of PA, Bristol-Myers Squibb

Other Relationships: BP

Research Funding: Pfizer, Amgen, Bristol-Myers Squibb, Novartis

Consulting or Advisory Role: Boehringer Ingelheim, Foamix, Novartis, Novocure, Quintiles, AstraZeneca, Legacy Healthcare, Janssen Research & Development, Adgero Bio Pharmaceuticals

Research Funding: Berg Pharma, Bristol-Myers Squibb

No conflicts to report

No conflicts to report

Leadership: Cellworks, LifeLink

Consulting or Advisory Role: Integra

Consulting or Advisory Role: Magellan Health

Consulting or Advisory Role: Clovis Oncology, Array BioPharma, Incyte

Research Funding: Seattle Genetics, Janssen Oncology

Travel, Accommodations, Expenses: Clovis Oncology, Array BioPharma

Honoraria: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Consulting or Advisory Role: Genentech/Roche, Amgen, Bayer/Onyx, Taiho Pharmaceutical, Caris Life Sciences, Celgene

Speakers' Bureau: Genentech/Roche, Amgen, Bayer/Onyx

Research Funding: Bayer/Onyx, Genentech/Roche, Pfizer, Amgen, Boehringer Ingelheim, MedImmune

No conflicts to report

Consulting or Advisory Role: AbbVie, Aduro, Association of Community Cancer Centers, bioTheranostics, Boston Biomedical, Bristol-Myers Squibb, Eli Lilly, Foundation Medicine, Genentech, Genomic Health, Heron, Novartis, Taiho

No conflicts to report

Consulting or Advisory Role: Boehringer Ingelheim

Research Funding: Boehringer Ingelheim, AstraZeneca, Exelixis, Novartis, MedImmune, Merck, Genentech/Roche, Lilly, Bayer

Consulting or Advisory Role: Gerson Lehrman Group, Caris Life Sciences

Stock & Other Ownership Interests: AuraSense LLC, Nanosphere Inc.

Honoraria: Celgene, Pharmacyclics, Janssen Biotech, Valeant Pharmaceuticals International

Consulting or Advisory Role: Celgene, Genetech Health Practices Consulting, Seattle Genetics

Research Funding: Celgene, Lilly

Honoraria: Pfizer, Amgen, Bristol-Myers Squibb, Tesaro

Consulting or Advisory Role: Amgen, Bristol-Myers Squibb, Pfizer, Helsinn Therapeutics

Speakers' Bureau: Genentech/Roche

Research Funding: Helsinn Therapeutics

Honoraria: Genomic Health, Eisai, Genentech/Roche, Celgene

Consulting or Advisory Role: Genentech/Roche, Pfizer, Celgene, Eisai

Speakers' Bureau: Genomic Health, Eisai, Genentech/Roche, Celgene

Research Funding: Bayer

Travel, Accommodations, Expenses: Genomic Health, Genentech/Roche, Eisai, Celgene

Consulting or Advisory Role: 3M, BlueCross and BlueShield of Michigan, Amgen

Leadership: Syndax

Stock & Other Ownership Interests: Syndax

Honoraria: Symphogen

Consulting or Advisory Role: Symphogen, Coherus Biosciences, Radius Health, Peregrine Pharmaceuticals, Taiho Pharmaceutical

Research Funding: Genentech/Roche

Travel, Accommodations, Expenses: Nektar, Radius Health, Taiho Pharmaceutical

Employment: UpToDate

Patents, Royalties, & Other Intellectual Property: UpToDate, Royalties from Oxford Textbook of Cancer Communication, co-editor

Travel, Accommodations, Expenses: GEOMC, Inc. Seoul, Korea

No conflicts to report as of 7/13/18

No conflicts to report

Stock & Other Ownership Interests: GlaxoSmithKline, Novartis, Teva, Medtronic, Biogen, Bristol-Myers Squibb, Celgene, Pfizer, Immunogen, Isis Pharmaceuticals, Johnson & Johnson, Merck, United Health Group, Vertex, UCAN

Research Funding: Merck

Patents, Royalties, & Other Intellectual Property: Jones and Bartlett Publisher

No conflicts to report

Consulting or Advisory Role: Genomic Health

Travel, Accommodations, Expenses: TEVA, Tel Aviv

Consulting or Advisory Role: Merck, Pfizer

Honoraria: Bayer, Bristol-Myers Squibb, Fresenius Kabi, Roche, Pfizer

Consulting or Advisory Role: Bayer, Pfizer

Speakers' Bureau: Bayer, Daiichi Sankyo

Travel, Accommodations, Expenses: Pfizer

No conflicts to report

Honoraria: Roche, Novartis, Pfizer, MSD Oncology, Lilly

Research Funding: Roche

Travel, Accommodations, Expenses: Celgene, MSD Oncology, Roche, Novartis

Leadership: IBA - Ion Beam Applications

Consulting or Advisory Role: IBA

Travel, Accommodations, Expenses: IBA

Consulting or Advisory Role: AstraZeneca, Amgen, Boehringer Ingelheim

Speakers' Bureau: Roche

Stock & Other Ownership Interests: Agenus

Consulting or Advisory Role: Genomic Health, Atlantic Sante, Celtic Biotech, SCM Lamallen Toledano Bollet, Fleury Michon

Employment: The Chinese University of Hong Kong

Leadership: Sanomics Limited

Stock & Other Ownership Interests: Sanomics Limited, Cirina

Honoraria: AstraZeneca, Roche/Genentech, Lilly, Bristol-Myers Squibb, Boehringer Ingelheim, Novartis, Merck Sharp & Dohme, Pfizer

Consulting or Advisory Role: AstraZeneca, Roche/Genentech, Lilly, Merck Serono, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, Novartis, Clovis Oncology, Vertex, SFJ Pharmaceuticals Group, ACEA Biosciences, Merck Sharp & Dohme, geneDecode, Oncogenex, Celgene, Ignyta, Cirina

Research Funding: AstraZeneca, Boehringer Ingelheim, Pfizer, Novartis, SFJ Pharmaceuticals Group, Roche, Merck Sharp & Dohme, Clovis Oncology, Bristol-Myers Squibb, Taiho Pharmaceutical, Eisai

No conflicts to report

No conflicts to report

No conflicts to report

Consulting or Advisory Role: Bristol-Myers Squibb, AstraZeneca, MSD Oncology

Speakers' Bureau: MSD Oncology, Bristol-Myers Squibb

Travel, Accommodations, Expenses: Bristol-Myers Squibb, Pfizer

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.